Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.820
-0.030 (-1.05%)
Dec 3, 2024, 9:34 AM EST - Market open
Sana Biotechnology Employees
Sana Biotechnology had 328 employees as of December 31, 2023. The number of employees decreased by 93 or -22.09% compared to the previous year.
Employees
328
Change (1Y)
-93
Growth (1Y)
-22.09%
Revenue / Employee
n/a
Profits / Employee
-$932,338
Market Cap
629.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 328 | -93 | -22.09% |
| Dec 31, 2022 | 421 | 35 | 9.07% |
| Dec 31, 2021 | 386 | 121 | 45.66% |
| Dec 31, 2020 | 265 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 452 |
| Axogen | 428 |
| Simulations Plus | 247 |
| OrthoPediatrics | 247 |
| Monte Rosa Therapeutics | 133 |
| EyePoint Pharmaceuticals | 121 |
| CorMedix | 83 |
| Altimmune | 59 |
SANA News
- 7 days ago - Sana Biotechnology to Present at December 2024 Investor Conferences - GlobeNewsWire
- 13 days ago - Sana Biotechnology: The Story Becomes Murkier - Seeking Alpha
- 25 days ago - Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 4 weeks ago - Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025 - GlobeNewsWire
- 2 months ago - Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference - GlobeNewsWire
- 3 months ago - Sana Biotechnology to Present at September 2024 Investor Conferences - GlobeNewsWire
- 3 months ago - Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer - GlobeNewsWire
- 4 months ago - Sana Biotechnology cuts the ribbon at new manufacturing facility near Seattle - GeekWire